COVID‐19: Vulnerability and the power of privilege in a pandemic

Smith, James A.; Judd, Jenni

doi:10.1002/hpja.333

Cited by 274 publications

(270 citation statements)

References 17 publications

Supporting

Mentioning

240

Contrasting

Unclassified

Order By: Relevance

“…Many countries utilized quarantine and mobilization restrictions to control the spread; however, these measures may not be sufficient in developing countries such as Ecuador [23].…”

Section: Preventionmentioning

confidence: 99%

Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review

Hallo¹,

Rojas²,

Hallo

2020

Cureus

View full text Add to dashboard Cite

“…Many countries utilized quarantine and mobilization restrictions to control the spread; however, these measures may not be sufficient in developing countries such as Ecuador [23].…”

Section: Preventionmentioning

confidence: 99%

Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review

Hallo¹,

Rojas²,

Hallo

2020

Cureus

View full text Add to dashboard Cite

“…On March 11, 2020, WHO announced that COVID-19 constitutes a pandemic. [ 5 ] As of June 11, 2020, the cumulative number of diagnoses worldwide exceeded 7.6 million and the number of deaths exceeded 400000. The rapid spread of the pandemic worldwide has raised serious public health concerns.…”

Section: Introductionmentioning

confidence: 99%

Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations

2020

View full text Add to dashboard Cite

Up-to-date information on the current progress made in the research and development to control the global COVID-19 pandemic is important. The study aimed to analyze the clinical trial characteristics and vaccine development progress of the new Coronavirus Disease 2019 (COVID-19) registered with the World Health Organization International Clinical Trial Registry Platform (WHO ICTRP). A comprehensive search of COVID-19 clinical trials since the establishment of the ICTRP to June 11, 2020, was conducted to record and analyze relevant characteristics. Chi-Squared test was used to compare the statistical differences between different research types, interventions, and sources. A total of 3282 COVID-19 clinical trials in 17 clinical trial registration centers were registered with the WHO ICTRP. The main research sources for the present study were ClinicalTrials.gov and ChiCTR. There were significant differences in the parameters of study location ( P = .000), number of participants ( P = .000), study duration ( P = .001), research stage ( P = .000), randomization procedure ( P = .000), and blinding method ( P = .000) between the 2 registration sources. There were significant differences in all the parameters between different kinds of intervention methods. Hydroxychloroquine, plasma therapy, and Xiyanping injection were the high-frequency research drugs used. Ten different vaccine studies were registered under phases I-II. Amongst the studies researched, heterogeneity existed for various parameters. Differences in the type of study, interventions, and registration sources of the studies led to significant differences in certain parameters of the COVID-19 clinical trials. The statistics of high-frequency drugs and the progress of vaccine trials may provide an informative reference for the prevention and control of COVID-19.

show abstract

“…Similar to the precision medicine initiative of providing the right treatment to the right patient at the right time [ 73 ], a precision public health approach to health literacy calls for harnessing the power of resourceful life-course data to inform the right intervention to the right population at the right time [ 59 , 74 ]. In the context of COVID-19 [ 75 ], precision public health is particularly useful to design targeted interventions for populations by person, place, and time to promote better navigation of health care and disease prevention [ 76 ]. If a population has a higher proportion of persons with low health literacy, public messages could be provided to educate persons on where to obtain trustworthy information and when to seek health professionals [ 76 ].…”

Section: What Evidence Is Needed?mentioning

confidence: 99%

Moving Health Literacy Research and Practice towards a Vision of Equity, Precision and Transparency

Guo

Okan

2020

IJERPH

View full text Add to dashboard Cite

Over the past two decades, health literacy research has gained increasing attention in global health initiatives to reduce health disparities. While it is well-documented that health literacy is associated with health outcomes, most findings are generated from cross-sectional data. Along with the increasing importance of health literacy in policy, there is a lack of specificity and transparency about how to improve health literacy in practice. In this study, we are calling for a shift of current research paradigms from judging health literacy levels towards observing how health literacy skills are developed over the life course and practised in the real world. This includes using a life-course approach, integrating the rationale of precision public health, applying open science practice, and promoting actionable knowledge translation strategies. We show how a greater appreciation for these paradigms promises to advance health literacy research and practice towards an equitable, precise, transparent, and actionable vision.

show abstract

COVID‐19: Vulnerability and the power of privilege in a pandemic

Cited by 274 publications

References 17 publications

Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review

Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review

Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations

Moving Health Literacy Research and Practice towards a Vision of Equity, Precision and Transparency

Contact Info

Product

Resources

About